REVIEW
Accepted on 16 Jun 2025
Gastrointestinal stromal tumors with the use of ripretinib and sunitinib: realworld adverse event analysis based on the FDA adverse event reporting system (FAERS)
doi 10.3389/fphar.2025.1561937
- 140 views
8,016
Total downloads
26k
Total views and downloads
REVIEW
Accepted on 16 Jun 2025
ORIGINAL RESEARCH
Accepted on 13 Jun 2025
ORIGINAL RESEARCH
Published on 04 Jun 2025
REVIEW
Published on 09 Jan 2025
ORIGINAL RESEARCH
Published on 06 Jan 2025
ORIGINAL RESEARCH
Published on 18 Dec 2024
ORIGINAL RESEARCH
Published on 05 Nov 2024
ORIGINAL RESEARCH
Published on 18 Oct 2024
ORIGINAL RESEARCH
Published on 12 Jul 2024
REVIEW
Published on 19 Mar 2024
ORIGINAL RESEARCH
Published on 14 Dec 2023